|
1
|
Brodeur GM: Neuroblastoma: biological
insights into a clinical enigma. Nat Rev Cancer. 3:203–216. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maris JM, Hogarty MD, Bagatell R and Cohn
SL: Neuroblastoma. Lancet. 369:2106–2120. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shimada H, Umehara S, Monobe Y, et al:
International neuroblastoma pathology classification for prognostic
evaluation of patients with peripheral neuroblastic tumors: a
report from the Children’s Cancer Group. Cancer. 92:2451–2461.
2001.
|
|
4
|
Ross RA, Spengler BA, Domenech C, Porubcin
M, Rettig WJ and Biedler JL: Human neuroblastoma I-type cells are
malignant neural crest stem cells. Cell Growth Differ. 6:449–456.
1995.PubMed/NCBI
|
|
5
|
Walton JD, Kattan DR, Thomas SK, et al:
Characteristics of stem cells from human neuroblastoma cell lines
and in tumors. Neoplasia. 6:838–845. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ross RA and Spengler BA: Human
neuroblastoma stem cells. Semin Cancer Biol. 17:241–247. 2007.
View Article : Google Scholar
|
|
7
|
Babaie Y, Herwig R, Greber B, et al:
Analysis of Oct4-dependent transcriptional networks regulating
self-renewal and pluripotency in human embryonic stem cells. Stem
Cells. 25:500–510. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Du Z, Jia D, Liu S, et al: Oct4 is
expressed in human gliomas and promotes colony formation in glioma
cells. Glia. 57:724–733. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chiou SH, Wang ML, Chou YT, et al:
Coexpression of Oct4 and Nanog enhances malignancy in lung
adenocarcinoma by inducing cancer stem cell-like properties and
epithelial-mesenchymal transdifferentiation. Cancer Res.
70:10433–10444. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ikushima H, Todo T, Ino Y, et al:
Glioma-initiating cells retain their tumorigenicity through
integration of the Sox axis and Oct4 protein. J Biol Chem.
286:41434–41441. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu CG, Lu Y, Wang BB, et al: Clinical
implications of stem cell gene Oct-4 expression in breast cancer.
Ann Surg. 253:1165–1171. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Das B, Tsuchida R, Malkin D, Koren G,
Baruchel S and Yeger H: Hypoxia enhances tumor stemness by
increasing the invasive and tumorigenic side population fraction.
Stem Cells. 26:1818–1830. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Melone MA, Giuliano M, Squillaro T, et al:
Genes involved in regulation of stem cell properties: studies on
their expression in a small cohort of neuroblastoma patients.
Cancer Biol Ther. 8:1300–1306. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pietras A, Hansford LM, Johnsson AS, et
al: HIF-2alpha maintains an undifferentiated state in neural
crest-like human neuroblastoma tumor-initiating cells. Proc Natl
Acad Sci USA. 106:16805–16810. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Newton TC, Wolcott K and Roberts SS:
Comparison of the side populations in pretreatment and postrelapse
neuroblastoma cell lines. Transl Oncol. 3:246–251. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nishimura N, Hartomo TB, Pham TV, et al:
Epigallocatechin gallate inhibits sphere formation of neuroblastoma
BE(2)-C cells. Environ Health Prev Med. 17:246–251. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pezzolo A, Parodi F, Marimpietri D, et al:
Oct-4(+)/Tenascin C(+) neuroblastoma cells serve as progenitors of
tumor-derived endothelial cells. Cell Res. 21:1470–1486. 2011.
|
|
18
|
Lois C, Hong EJ, Pease S, Brown EJ and
Baltimore D: Germline transmission and tissue-specific expression
of transgenes delivered by lentiviral vectors. Science.
295:868–872. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen YC, Hsu HS, Chen YW, et al: Oct-4
expression maintained cancer stem-like properties in lung
cancer-derived CD133-positive cells. PLoS One. 3:e26372008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kutner RH, Zhang XY and Reiser J:
Production, concentration and titration of pseudotyped HIV-1-based
lentiviral vectors. Nat Protoc. 4:495–505. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cui H, Ma J, Ding J, Li T, Alam G and Ding
HF: Bmi-1 regulates the differentiation and clonogenic self-renewal
of I-type neuroblastoma cells in a concentration-dependent manner.
J Biol Chem. 281:34696–34704. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Marzi I, D’Amico M, Biagiotti T, et al:
Purging of the neuroblastoma stem cell compartment and tumor
regression on exposure to hypoxia or cytotoxic treatment. Cancer
Res. 67:2402–2407. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mahller YY, Williams JP, Baird WH, et al:
Neuroblastoma cell lines contain pluripotent tumor initiating cells
that are susceptible to a targeted oncolytic virus. PLoS One.
4:e42352009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Coulon A, Flahaut M, Muhlethaler-Mottet A,
et al: Functional sphere profiling reveals the complexity of
neuroblastoma tumor-initiating cell model. Neoplasia. 13:991–1004.
2011.PubMed/NCBI
|
|
25
|
Niwa H: How is pluripotency determined and
maintained? Development. 134:635–646. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chiou SH, Yu CC, Huang CY, et al: Positive
correlations of Oct-4 and Nanog in oral cancer stem-like cells and
high-grade oral squamous cell carcinoma. Clin Cancer Res.
14:4085–4095. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim R-J and Nam J-S: OCT4 Expression
enhances features of cancer stem cells in a mouse model of breast
cancer. Lab Anim Res. 27:147–152. 2011. View Article : Google Scholar : PubMed/NCBI
|
